Structures by: Grobelny P.
Total: 40
Pyrazinecarboxamide:4-aminosalicylic acid co-crystal hydrate
C7H7NO3,C5H5N3O,H2O
CrystEngComm (2011) 13, 13 4358
a=6.7780(14)Å b=7.0380(14)Å c=15.050(3)Å
α=96.59(3)° β=98.42(3)° γ=105.27(3)°
Isoniazid:4-aminosalicylic acid co-crystal
C13H14N4O4,C7H7NO3,C6H7N3O
CrystEngComm (2011) 13, 13 4358
a=21.837(2)Å b=16.5073(14)Å c=7.2252(6)Å
α=90° β=90° γ=90°
Isoniazid:4-aminosalicylic acid co-crystal
C13H14N4O4,C7H7NO3,C6H7N3O
CrystEngComm (2011) 13, 13 4358
a=21.845(2)Å b=16.5081(13)Å c=7.2355(6)Å
α=90° β=90° γ=90°
Isoniazid:4-aminosalicylic acid co-crystal
C13H14N4O4,C7H7NO3,C6H7N3O
CrystEngComm (2011) 13, 13 4358
a=21.879(9)Å b=16.520(7)Å c=7.263(3)Å
α=90° β=90° γ=90°
Isoniazid:4-aminosalicylic acid co-crystal
C7H7NO3,C6H7N3O
CrystEngComm (2011) 13, 13 4358
a=21.893(2)Å b=16.5073(18)Å c=7.2990(7)Å
α=90° β=90° γ=90°
Isoniazid:4-aminosalicylic acid co-crystal
C13H14N4O4,C7H7NO3,C6H7N3O
CrystEngComm (2011) 13, 13 4358
a=21.859(2)Å b=16.5084(14)Å c=7.2459(6)Å
α=90° β=90° γ=90°
Isoniazid:4-aminosalicylic acid co-crystal
C7H7NO3,C6H7N3O
CrystEngComm (2011) 13, 13 4358
a=21.926(10)Å b=16.514(8)Å c=7.310(3)Å
α=90° β=90° γ=90°
Isoniazid:4-aminosalicylic acid co-crystal
C13H14N4O4,C7H7NO3,C6H7N3O
CrystEngComm (2011) 13, 13 4358
a=21.889(2)Å b=16.5223(14)Å c=7.2750(6)Å
α=90° β=90° γ=90°
Isoniazid:4-aminosalicylic acid co-crystal
C7H7NO3,C6H7N3O
CrystEngComm (2011) 13, 13 4358
a=21.942(2)Å b=16.515(2)Å c=7.3435(8)Å
α=90° β=90° γ=90°
Isoniazid:4-aminosalicylic acid co-crystal
C13H14N4O4,C7H7NO3,C6H7N3O
CrystEngComm (2011) 13, 13 4358
a=21.840(2)Å b=16.5060(17)Å c=7.2541(7)Å
α=90° β=90° γ=90°
Isoniazid:4-aminosalicylic acid co-crystal
C13H14N4O4,C7H7NO3,C6H7N3O
CrystEngComm (2011) 13, 13 4358
a=21.893(10)Å b=16.515(7)Å c=7.283(3)Å
α=90° β=90° γ=90°
Isoniazid:4-aminosalicylic acid co-crystal
C7H7NO3,C6H7N3O
CrystEngComm (2011) 13, 13 4358
a=21.969(2)Å b=16.485(2)Å c=7.3209(9)Å
α=90° β=90° γ=90°
C18H15ClN2O2S
C18H15ClN2O2S
CrystEngComm (2012) 14, 18 5785
a=29.950(12)Å b=4.995(2)Å c=22.828(10)Å
α=90.00° β=90.00° γ=90.00°
C18H15ClN2O2.69S
C18H15ClN2O2.69S
CrystEngComm (2012) 14, 18 5785
a=10.889(2)Å b=12.359(3)Å c=12.803(3)Å
α=90.00° β=93.496(7)° γ=90.00°
C18H16ClN2O2.5S
C18H16ClN2O2.5S
CrystEngComm (2012) 14, 18 5785
a=20.9182(15)Å b=12.4873(8)Å c=12.8222(8)Å
α=90.00° β=90.00° γ=90.00°
Orcinol:Urea
C7H8O2,2(CH4N2O)
Crystal Growth & Design (2011) 11, 6 2637
a=16.602(3)Å b=10.546(2)Å c=7.0700(14)Å
α=90° β=99.30(3)° γ=90°
Orcinol:N,NdimethylaminoPyridne
2(C7H10N2),2(C7H8O2),CHCl3
Crystal Growth & Design (2011) 11, 6 2637
a=17.213(3)Å b=8.4780(17)Å c=21.650(4)Å
α=90° β=91.04(3)° γ=90°
Orcinol: N,N-dimethyl,4-aminopyridine
2(C7H10N2),C7H8O2
Crystal Growth & Design (2011) 11, 6 2637
a=7.8586(19)Å b=8.1455(19)Å c=16.239(4)Å
α=83.929(6)° β=81.521(6)° γ=86.524(6)°
Orcinol:Pyrazine
C7H8O2,0.5(C4H4N2)
Crystal Growth & Design (2011) 11, 6 2637
a=6.9967(14)Å b=8.5801(17)Å c=13.531(3)Å
α=90° β=95.16(3)° γ=90°
Orcinol:Piperazine
C7H8O2,C4H10N2
Crystal Growth & Design (2011) 11, 6 2637
a=7.2456(12)Å b=12.316(2)Å c=12.590(2)Å
α=90° β=96.268(7)° γ=90°
Orcinol:Acridine
2(C13H9N),C7H8O2
Crystal Growth & Design (2011) 11, 6 2637
a=7.837(2)Å b=9.702(3)Å c=17.830(5)Å
α=98.229(7)° β=100.908(7)° γ=103.819(7)°
Orcinol:Pyrimidine
C7H8O2,C4H5N3
Crystal Growth & Design (2011) 11, 6 2637
a=8.7636(7)Å b=10.9081(9)Å c=13.3171(11)Å
α=112.508(8)° β=104.169(7)° γ=92.570(7)°
Orcinol
C7H8O2
Crystal Growth & Design (2011) 11, 6 2637
a=20.060(3)Å b=20.060(3)Å c=6.4230(13)Å
α=90° β=90° γ=90°
Orcinol:Phenantrholine
2(C12H8N2),C7H8O2
Crystal Growth & Design (2011) 11, 6 2637
a=13.783(7)Å b=13.520(7)Å c=15.981(6)Å
α=90° β=124.11(3)° γ=90°
Orcinol:Acridine Hydrate
2(C13H9N),2(C7H8O2),H2O
Crystal Growth & Design (2011) 11, 6 2637
a=9.3390(7)Å b=25.441(2)Å c=13.7503(11)Å
α=90° β=90° γ=90°
Orcinol:1245Tetracyanobenzene
C7H8O2,1.5(C10H2N4)
Crystal Growth & Design (2011) 11, 6 2637
a=7.2000(14)Å b=7.5989(15)Å c=35.894(7)Å
α=90° β=91.01(3)° γ=90°
Orcinol:4(N,N-dimethylaminopyridine
C7H10N2,C7H8O2
Crystal Growth & Design (2011) 11, 6 2637
a=10.498(8)Å b=8.887(7)Å c=15.557(9)Å
α=90° β=113.80(4)° γ=90°
OrcinolHexamine
C6H12N4,C7H8O2
Crystal Growth & Design (2011) 11, 6 2637
a=17.572(3)Å b=21.702(4)Å c=7.0650(14)Å
α=90° β=90° γ=90°
Orcinol:Nicotinamide
C7H8O2,4(C6H6N2O),H2O
Crystal Growth & Design (2011) 11, 6 2637
a=7.9260(16)Å b=12.560(3)Å c=16.750(3)Å
α=96.16(3)° β=99.97(3)° γ=98.56(3)°
Orcinol:Isonicotinamide
C7H8O2,2(C6H6N2O)
Crystal Growth & Design (2011) 11, 6 2637
a=33.630(7)Å b=7.2600(15)Å c=15.358(3)Å
α=90° β=95.65(3)° γ=90°
(Orcinol:Nicotinamide)
C7H8O2,4(C6H6N2O)
Crystal Growth & Design (2011) 11, 6 2637
a=8.2817(12)Å b=10.9094(12)Å c=16.600(2)Å
α=99.961(9)° β=96.163(7)° γ=93.253(5)°
Orcinol form II
C7H8O2
Crystal Growth & Design (2011) 11, 6 2637
a=13.784(14)Å b=16.174(17)Å c=24.55(2)Å
α=90° β=90° γ=90°
Orcinol:Quinoxaline
C7H8O2,2(C8H6N2)
Crystal Growth & Design (2011) 11, 6 2637
a=7.0702(14)Å b=14.274(3)Å c=19.730(4)Å
α=90° β=99.05(3)° γ=90°
Orcinol:Quinoxaline2:1
2(C7H8O2),C8H6N2
Crystal Growth & Design (2011) 11, 6 2637
a=8.2900(17)Å b=9.990(2)Å c=12.690(3)Å
α=104.66(3)° β=103.82(3)° γ=96.33(3)°
Orcinol:N,NdimethylaminoPyridne
C7H8O2,2(C7H10N2)
Crystal Growth & Design (2011) 11, 6 2637
a=13.845(3)Å b=9.6116(17)Å c=15.059(3)Å
α=90° β=97.096(7)° γ=90°
Orcinol:H2O
C7H8O2,H2O
Crystal Growth & Design (2011) 11, 6 2637
a=9.899(2)Å b=7.9510(16)Å c=9.1707(18)Å
α=90° β=96.88(3)° γ=90°
C18H15ClN2O2S
C18H15ClN2O2S
CrystEngComm (2012) 14, 18 5785
a=8.0520(16)Å b=10.412(2)Å c=10.455(2)Å
α=85.62(3)° β=83.17(3)° γ=80.56(3)°
Orcinol:4-CyanoPyridine
2(C7H8O2),C6H4N2
Crystal Growth & Design (2011) 11, 6 2637
a=7.495(2)Å b=17.596(5)Å c=14.389(4)Å
α=90° β=97.656(7)° γ=90°
Orcinol:aminodimethylpyrimidine
2(C6H9N3),C7H8O2
Crystal Growth & Design (2011) 11, 6 2637
a=8.4494(9)Å b=12.3620(13)Å c=19.748(2)Å
α=83.323(7)° β=77.689(7)° γ=89.497(6)°
Orcinol:Phenazine
2(C12H8N2),C7H8O2
Crystal Growth & Design (2011) 11, 6 2637
a=8.1760(16)Å b=9.2940(19)Å c=16.888(3)Å
α=102.32(3)° β=102.03(3)° γ=93.53(3)°